12 November 2020

Polymyalgia Rheumatica

Febuxostat as safe as allopurinol in FAST study

12 November 2020

Biologics Conditions

Even low-dose glucocorticoids have risks

12 November 2020

Ankylosing Spondylitis Communicable Diseases Corticosteroids Gout NDIA Scleroderma Spondyloarthritis

Some RA patients stuck in a drug switch cycle

12 November 2020

Systemic vasculitis Women

Thalidomide survivors – Where are they now?

4 November 2020

Analgesics Conditions Pharmacy Guild of Australia

COVID or giant cell arteritis: how to spot the difference

4 November 2020

Analgesics Conditions Pain

Post-surgery pain and trusting biosimilars

4 November 2020

Conditions Pharmacy Guild of Australia Ross River Virus

Overcoming challenges in GCA and PMR management

4 November 2020

Conditions

Attack of the phages

20 October 2020

Conditions Diet

Mediterranean diet to the rescue

20 October 2020

Conditions Technology

Health apps: what are they good for?

20 October 2020

Conditions Patient Perspective

How patients want their healthcare team to communicate

20 October 2020

Analgesics Conditions Scleroderma

First head-to-head trial for rival PsA biologics

12 October 2020

Analgesics Ankylosing Spondylitis Conditions Scleroderma

IL-17A inhibitor carries fewer TB risks

7 October 2020

Ankylosing Spondylitis Conditions Spondyloarthritis

More infections in RA patients on baricitinib

7 October 2020

Conditions Telehealth

The Witch, the Lion and the Telephone

2 October 2020

Analgesics Axial spondyloarthritis Biologics Conditions Gout Spondyloarthritis

Europe approves filgotinib despite FDA qualms